We’re pleased to share that Omar Ali, Head of Payers at Verpora, will be delivering a keynote address at the 11th International Cancer, Oncology and Therapy Conference in Dubai.
This global gathering brings together oncology experts, healthcare leaders, and researchers from across disciplines to exchange ideas and accelerate progress in cancer care. The conference’s focus on innovation, cross-border collaboration, and patient outcomes aligns closely with Verpora’s work at the intersection of pricing, access, and payer strategy.
Keynote Session: Can we afford a cure?
Paying for innovation with new cancer medicines
In this session, Omar explores how rising innovation in oncology is driving up the cost of treatment—and why the question of affordability can’t be ignored. As high-cost therapies become more common, traditional pricing models are increasingly unsustainable. Drawing on real-world case studies and international examples, Omar will unpack how governments and manufacturers are turning to innovative contracting and value-based agreements to deliver access to life-saving therapies.
From performance-linked reimbursement models to bold, outcome-based deals, the talk showcases how creativity in negotiation is helping make the unaffordable affordable—shifting the conversation from price to value.
About the Conference
Now in its 11th year, the International Cancer, Oncology and Therapy Conference serves as a critical platform for sharing breakthroughs in treatment, building global partnerships, and advancing the collective mission of improving cancer care. This year’s programme features keynote talks, panel discussions, and innovation showcases from across the research, clinical, and policy landscape.
Representing Verpora
Omar Ali
BSc(Hons)Pharm, DipClinPharm, MRPharmS, ACPP
Head of Payers, Verpora & Former Adviser to NICE
More Info & Registration
More information and registration directly via the 11CANCER25 website